drugset / Trial / NCT01309581

Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression

NCT01309581

Terminated 3 enrolled James Murrough
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objectives of this study are to investigate the potential for ketamine anesthesia to increase the antidepressant efficacy of Electroconvulsive therapy (ECT) and to decrease acute ECT-induced adverse cognitive effects.

Timeline

Start
2010-04
Primary completion
2010-10
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 1 mg/kg Intravenous
Subject Ketamine Small molecule 2 mg/kg Intravenous
Comparator Methohexital Small molecule 1 mg/kg Intravenous